Expensify: The 250% Rally Has Run Far Ahead of the Turnaround Evidence

Expensify (NASDAQ: EXFY) surged 36% on the day after reporting Q2 2026 results, pushing the stock to $2.69 — a level that puts it near its 52-week high of $2.80 and nearly 250% above its October low of $0.69. The move reflects enthusiasm for a company that flipped to adjusted profitability and raised its free-cash-flow guidance.

The headline numbers look clean. The underlying business tells a different story. Revenue is still declining. User counts are slipping. Management admits they cannot say when their new platform will offset the erosion in the old one. At the current price, the risk/reward has shifted from asymmetric upside to a valuation that already assumes the transition works.

Rating: Hold. Wait for the growth proof before paying up.

What actually drove the pop

The rally was engineered as much as it was earned. Two-thirds of the per-share improvement came from a 7% reduction in shares outstanding, not from top-line growth or margin expansion.

In Q2, Expensify repurchased 6.8 million Class A shares — a modified Dutch auction tender offer for 6.1 million shares at $1.20 and open-market purchases of 712,000 shares at $1.63. The tender offer was substantially undersubscribed; the company aimed to buy up to $25 million worth and only received $7.4 million in tenders. They bought it anyway.

That share reduction is what turned a modest absolute profit into a per-share beat. Non-GAAP net income came in at $3.4 million, a swing from a non-GAAP loss a year ago. Adjusted EBITDA (earnings before interest, taxes, depreciation, and amortization — a rough cash-earnings proxy that excludes stock-based compensation) hit $6.6 million versus a negative result in the prior-year quarter. GAAP net loss still came in at $3.9 million, though that narrowed from $8.8 million a year earlier.

The share math matters because it masks the fact that Expensify's total profit pool is tiny. A $3.4 million quarterly profit on a $135 million annual revenue run-rate is not a scaling business. It is a shrinking one that cut costs enough to eke out non-GAAP income.

Revenue is still declining

Q2 revenue was $33.9 million, down 5% year-over-year. The decline follows a 6% miss in Q1, a 3% decline in Q4, and a 4.3% contraction over the trailing twelve months. Four consecutive quarters of revenue erosion is not a temporary blip; it is a trend.

The decline is structural, not cyclical. Expensify is in the middle of killing its own cash cow. The company shut off new customer sign-ups on its legacy Classic platform and is trying to migrate those users to "New Expensify," a rebuilt product around mobile, chat, and AI workflows. Classic is described by management as a "mature, slowly decreasing" customer base. New Expensify is "small but growing rapidly." The timing for New to fully offset Classic's decline remains, in management's own words, "uncertain."

That uncertainty is the load-bearing fact of this story.

New Expensify ARR (annual recurring revenue) from direct sign-ups — excluding migrated Classic users — grew more than 250% year-over-year to over $10 million. CFO Ryan Schaffer estimated ARR grew from roughly $7 million at the end of Q1 to about $12 million by the end of Q2. On an annual basis, that's approximately $3 million per quarter, or about 8% of total quarterly revenue.

New Expensify now accounts for 56% of users and has nearly 12,000 customers. Those are directionally right milestones. But a $12 million ARR base replacing a $135 million revenue business requires either a dramatic acceleration or years of linear growth. Management did not provide a timeline.

The free cash flow raise

The second pillar of the rally is the raised full-year free-cash-flow guidance. Management lifted the forecast to $12 million–$14 million, up sharply from the prior range of $6 million–$9 million. Q2 delivered $6.4 million in free cash flow, a 2% year-over-year increase and a 162% sequential jump from Q1's thin number.

The raise is real, but its composition is important. Part of it reflects lower one-time costs — a class-action lawsuit settlement was resolved in Q1, removing a drag on the outlook. Part reflects the revenue decline itself: smaller top-line growth means smaller operating scale and smaller absolute costs when you're cutting. The company is not generating more cash because it is growing; it is generating more cash because it is shrinking the cost base faster than revenue.

At the midpoint of the new guidance — $13 million — the enterprise value of $179.5 million implies an EV/FCF multiple of roughly 13.8x. That is not cheap for a company whose revenue is declining 5% and whose management cannot commit to when growth returns. By comparison, Domo (NASDAQ: DOMO), another small-cap SaaS name in distress, trades at 0.58x revenue on an enterprise value of $153 million. Expensify's 1.3x EV/sales is a premium for a business that has not yet proven the premium is earned.

The user count is the early warning signal

Average paid members during Q2 were 640,000. By July, they dropped to 634,000. Management attributed the decline to seasonal summer travel patterns and expected improvement in Q3. That may be true for a single month, but it fits a broader pattern: the Classic base is bleeding users, and New Expensify has not added enough to make up the difference.

At 640,000 paid members and $33.9 million in quarterly revenue, average revenue per user is about $53 per quarter, or roughly $212 annualized. That is a modest take rate for a business that processes expenses, issues corporate cards, and manages travel billing. Interchange revenue from the Expensify Card was $5.9 million, up 12% year-over-year, which is a bright spot. But card revenue is still a fraction of total revenue and doesn't solve the core platform-transition risk.

What's being hyped versus what's proven

Expensify launched an MCP (Model Context Protocol) integration in June, allowing third-party AI assistants like ChatGPT and Claude to access expense data through natural language. Custom AI agents are now generally available. Management is considering usage-based monetization for AI capabilities but has not announced anything specific.

This is the kind of AI narrative that sounds impressive on an earnings call and adds zero to the P&L today. AI-related spending is already increasing, and management is actively exploring ways to reduce it. That is not the posture of a company that has found a scalable AI revenue model. It's the posture of a company spending on product differentiation while watching the top line slide.

The one product initiative with actual traction is Consolidated Travel Billing, which has a large waitlist and targets larger enterprise customers. If that converts, it could be a meaningful revenue bridge. For now, it's a waitlist, not a revenue stream.

The valuation question

At $245 million in market cap and $179.5 million in enterprise value (with $65.8 million in cash against $50.8 million in debt), Expensify is not priced for perfection. But it is priced for a working transition. The 1.78x price-to-sales multiple and 1.3x EV/sales assume that New Expensify will successfully replace Classic revenue within a reasonable timeframe.

The evidence does not yet support that assumption. New Expensify ARR is $12 million against a total revenue base of $135 million annualized. Even if New Expensify doubles its ARR each quarter — an aggressive case — it would take two years to approach half the current revenue base. Classic is declining in the meantime.

The stock has moved from $0.69 to $2.69 in six months. At the low, themarket was pricing in potential collapse. At the current level, it is pricing in a successful turnaround. The company has not earned either extreme. It has earned a middle ground: a small business generating $8 million in trailing free cash flow, with a balance sheet that isn't breaking, and a product transition that is real but unproven at scale.

Risks that change the rating

Three scenarios would push this from Hold to Buy:

• New Expensify ARR accelerates to $20 million+ within two quarters, showing the growth inflection management has been describing.
• A quarter of revenue growth — even modest — that breaks the four-quarter decline streak.
• The stock pulls back below $1.50, where the EV/FCF multiple compresses into territory that gives room for execution risk.

Two scenarios would push it from Hold to Sell:

• Revenue decline accelerates past 10% as Classic users exit faster than anticipated.
• Paid member count drops below 600,000 and stays there, confirming structural user loss.

Bottom line

Expensify is a company executing a legitimate but difficult platform transition. The cash generation is real, the balance sheet is stable, and the new product has genuine user adoption. The 7% share buyback was an aggressive move that improved per-share metrics without improving the business.

The stock's 250% move from its low has priced in the successful completion of that transition before the evidence is there. Management's admission that the timing remains uncertain should be read at face value, not dismissed as earnings-call caution. At $2.69, there is not enough upside left to compensate for the execution risk.

The next earnings report in late October will be the first real test. If New Expensify ARR has moved from $12 million to somewhere above $16 million and revenue holds above $33 million, the turnaround thesis gets stronger. If not, the current price is a premium for a story that hasn't proven itself yet.